[
  {
    "ts": "2025-10-06T15:33:00+00:00",
    "headline": "Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years.",
    "summary": "The  SPDR S&P Biotech  exchange-traded fund, which tracks a broad selection of biotech names, has shot up 8.9% since September 25, just more than a week ago.  The biotech run-up over the past week or so has been fueled by the same drug-pricing deal between  Pfizer  and President Donald Trump that set off a surge in Big Pharma share prices last Tuesday, along with a spate of acquisitions.  “Investors are naturally jittery, since prior rallies haven’t been sustained,” Cantor Fitzgerald analysts Josh Schimmer and Eric Schmidt wrote in a note on Friday.",
    "url": "https://www.barrons.com/articles/biotech-stocks-sector-7ce04668?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "3df188b8-25cf-3d84-9780-7466e2499d15",
      "content": {
        "id": "3df188b8-25cf-3d84-9780-7466e2499d15",
        "contentType": "STORY",
        "title": "Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years.",
        "description": "",
        "summary": "The  SPDR S&P Biotech  exchange-traded fund, which tracks a broad selection of biotech names, has shot up 8.9% since September 25, just more than a week ago.  The biotech run-up over the past week or so has been fueled by the same drug-pricing deal between  Pfizer  and President Donald Trump that set off a surge in Big Pharma share prices last Tuesday, along with a spate of acquisitions.  “Investors are naturally jittery, since prior rallies haven’t been sustained,” Cantor Fitzgerald analysts Josh Schimmer and Eric Schmidt wrote in a note on Friday.",
        "pubDate": "2025-10-06T15:33:00Z",
        "displayTime": "2025-10-06T15:33:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3df188b8-25cf-3d84-9780-7466e2499d15/biotech-stocks-are-up-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/5b87ae5eee5e23955039c71dcae4a3e8",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pASWUiuvqY1FXySUWh2LUg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/5b87ae5eee5e23955039c71dcae4a3e8.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WRNl25CBcq2JoP9AvcdBCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/5b87ae5eee5e23955039c71dcae4a3e8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/biotech-stocks-sector-7ce04668?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "XBI"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-06T03:14:31+00:00",
    "headline": "Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Best Affordable Dividend Stocks to Buy Now. Bristol-Myers Squibb Company (NYSE:BMY) is an American pharmaceutical giant that operates in multiple countries and is based in New Jersey. In the second quarter, the company’s growth portfolio recorded double-digit sales, and at least seven products recorded more than […]",
    "url": "https://finance.yahoo.com/news/investing-smart-bristol-myers-squibb-031431662.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "f7781bae-8e83-345f-bb0f-0d5dc583f34e",
      "content": {
        "id": "f7781bae-8e83-345f-bb0f-0d5dc583f34e",
        "contentType": "STORY",
        "title": "Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Best Affordable Dividend Stocks to Buy Now. Bristol-Myers Squibb Company (NYSE:BMY) is an American pharmaceutical giant that operates in multiple countries and is based in New Jersey. In the second quarter, the company’s growth portfolio recorded double-digit sales, and at least seven products recorded more than […]",
        "pubDate": "2025-10-06T03:14:31Z",
        "displayTime": "2025-10-06T03:14:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w_.mq2hxLlg_y2nUTx72ng--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6o8Kx8kFVS_oEolQVNGNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investing-smart-bristol-myers-squibb-031431662.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investing-smart-bristol-myers-squibb-031431662.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]